Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
Clinical trial NCT02540954 · COMPLETED
Trial details
- NCT number
- NCT02540954
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-29
- Primary completion
- 2019-12-24
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.